dabrafenib trametinib

Details

Files

Generic Name:

Project Status:

Pending

Therapeutic Area:

Head and neck cancer

Call for patient/clinician input open:

October 17, 2024

Brand Name:

TBC

Project Line:

Reimbursement Review

Project Number:

PX0373-000

Call for patient/clinician input closed:

December 6, 2024

Submission Type:

Non-sponsored Submission

Indications:

Indicated for BRAF V600E mutant anaplastic thyroid cancer.

Last Updated : October 17, 2024